logo

EVIDENCE • EXPERIENCE • OUTCOMES

INTELLIGENCE BYMDReviewer
Home
About
Peptides
Contact
Back
  • No Preview Available

C-KIT PHARMDX

Device
Generic:
Immunohistochemistry antibody assay, c-kit
Manufacturer:
dako north america, inc.
Drug Classes:
Not available
Reps:
Rep 1Signup or Login to view Reps
Rep 2Signup or Login to view Reps

👋No reviews yet — be the first!

Be the first verified prescriber to review C-KIT PHARMDX.

100% anonymous · NPI-verified

On this page

  • Synopsis

FDA label

  • Description
  • Indication and Usage

More

  • Approval history
  • Representatives
  • Reviews

Similar products

Synopsis
Generated with AlphaAI
Product:
C-KIT PHARMDX
Category:
Indication:
Mechanism:
Safety:
Dosing:
Patient:
Reviews:
No reviews yet
see more
Disclaimer: The synopsis and product information provided on Alpha.MD are derived from openFDA data and are for informational purposes only. This information may not be comprehensive, accurate, or up-to-date. Clinicians should exercise their own professional judgment in interpreting and using this information, and consult the official prescribing information for the most accurate and current details.

FDA label

From the official FDA prescribing information for C-KIT PHARMDX.

Description

Warnings and Precautions for use of the device are stated in the product labeling. Reagents Provided. The DakoCytomation c-Kit pharmDx™ assay kit contains 2 vials of immunohistochemical reagents and I 0 control slides bearing two formalin- fixed, paraffin-embedded cell line preparations. The first vial of immunohistochemical reagent consists of 9 mL of polyclonal Page 2 Summary of Safety and Effectiveness Data rabbit anti-human c-kit IgG in a Tris-HCl buffer, containing stabilizing protein and 0.015 mol/L sodium azide. The second vial contains 9 mL of polyclonal rabbit IgG at a greater than or equal to the positive anti-c-Kit concentration in a Tris-HCl buffer, containing stabilizing protein and 0.015 mol/L sodium azide. Positive and negative c-kit cell lines are provided on each control slide to be used as performance controls for the kit reagents. Each slide contains sections of two pelleted, formalin-fixed paraffin-embedded cell lines, which represent a moderate level of c-kit/CD 117 protein expression and no c-kit/CD117 expression. The IHC staining scores of the cell pellets are 2+ and 0. In addition, the following materials and reagents are necessary to perform the assay. • Wash Buffer (code S3006) • Dual Endogenous Enzyme Block (code S2003) • Target Retrieval Solution (code S 1699 & S 1700) • EnVision+ Rabbit (code K4002 & K4003) • DAB+ (code K3467 & K3468) Note: To ensure proper staining results, only these staining reagents should be used with c­ Kit pharmDx™. Deviations from this recommended protocol have not been validated. • Ammonium hydroxide, 15 mol/L diluted to 0.037 mol/L • Hematoxylin, alcohol or water-based such as DakoCytomation's Hematoxylin (code S3301 or S3302) • Coverslips • Water bath, capable of maintaining 95-99°C or pressure cooker, capable of heating up to!2!°C • Distilled or deionized water (reagent-quality water) • Drying oven, capable of maintaining 56--60°C • Ethanol, absolute and 95% • Light microscope ( 4x-40x objective magnification) • Mounting medium, such as DakoCytomation's Paramount (code S3025) • or DakoCytomation's Glycergel (code C0563) or DakoCytomation's Ultramount (code S1964) • Positive and negative tissues to use as process controls (see Quality control section) • Slides, Fisher's SuperFrost Plus, poly-L-lysine-coated slides, charged slides, • or DakoCytomation's Silanized Slides (code S3003) (see Specimen preparation section) • Staining jars or baths • Timer (capable of2-30 minute intervals) • Wash bottle • Xylene, toluene, or xylene substitutes • I mL pipette • Humid Chamber Page 3 Summary of Safety and Effectiveness Data Principle of Device Methodology The DakoCytomation c-Kit pharmDx™ assay is a standard immunohistochemical (IHC) assay to identify the c-kit/CD117 receptor expression in normal and neoplastic tissues. The c-Kit pharmDx™ IHC kit contains antibodies and control slides to complete an IHC staining procedure for formalin-fixed and paraffin-embedded gastrointestinal stromal tumor (GIST) specimens. c-Kit pharmDx™ assay contains rabbit polyclonal antibodies which binds a site on the internal domain of the c-kit oncoprotein in paraffin-embedded tissue sections and specifically detects the c-kit/CD117 protein inc-kit-expressing cells. The kit also contains a vial of matched negative control reagent and control slides. The remainder of the reagents necessary to obtain results is recommended in the "Materials required, but not supplied" section of the product labeling and must be purchased separately. The system is used with antigen enhancement reagent, endogenous peroxidase blocker, ready-to-use visualization reagent based on dextran technology, diamino-benzidine (DAB) chromogen substrate, and hematoxylin counterstain. Following incubation with the primary polyclonal antibodies to human c-kit/CD117 protein, which binds to the antigen in or on the cells, this kit recommends using a ready-to-use visualization reagent based on dextran technology. This reagent consists of both secondary goat anti-rabbit antibody molecules and horseradish peroxidase molecules linked to a common dextran polymer backbone, thus eliminating the need for sequential application oflink antibody and peroxidase conjugate. This reagent binds to the c-Kit antibody that bound to the c-kit protein in or on the cell. The enzymatic conversion of the subsequently added DAB chromogen results in formation of a visible reaction product at the antigen site. Each step is incubated for a precise time and temperature. At the end of each incubation step, sections are washed to stop the reaction and remove unbound material that would hinder the desired reaction in subsequent steps. The specimen is then counterstained and coverslipped. Results are interpreted by a pathologist using a light microscope. The presence of staining with a score of I+ or greater is considered to be positive, while no or faint staining below 1 + is considered negative. Control slides, containing two formalin-fixed paraffin-embedded human cell lines with staining intensity scores of2+ and 0, are provided for quality control of the kit reagent performance. Detailed instructions in the package insert for use of reagents, control materials and how to interpret their results are provided also to insure adequate assay control. The kit is · available in manual and automated configurations.

Indication and Usage

The c-Kit pharmDx™ assay is a qualitative immunohistochemical (IHC) kit system used on the Dako Autostainer, for the identification of c-kit protein/ CD 117 antigen (c-kit protein) expression in normal and neoplastic formalin-fixed paraffin-embedded tissues for histological evaluation. The c-Kit pharmDx™ rabbit polyclonal antibodies specifically detect the c-kit protein in CD 117 antigen-expressing cells. The c-Kit pharmDx™ is indicated as an aid in the differential diagnosis of gastrointestinal stromal tumors (GIST). After diagnosis of GIST, results from c-Kit pharmDx may be used as an aid in identifying those patients eligible for treatment with Gleevec™/Glivec® (imatinib mesylate). Results from hematoxylin and eosin (H&E) stains and a panel of antibodies can aid in the differential diagnosis of GIST. Interpretation must be made by a qualified pathologist, within the context of a patient's clinical history, proper controls, and other diagnostic tests

Approval history

Latest FDA approval: November 2, 2012

Representatives

J
John Doe
New York, US
Products:

Humira

Humira

J
John Doe
New York, US
Products:

Humira

Humira

Signup or Login to view Reps
You must have an account to view Reps detail
Already have an account? Login
There isn't any reviews posted yet. You can be the first to review the product